Operating Income - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NuVasive Inc
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Operating Income
$82.6m
CAGR 3-Years
13%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.7B
CAGR 3-Years
24%
CAGR 5-Years
9%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.6B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
13%

See Also

What is NuVasive Inc's Operating Income?
Operating Income
82.6m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Operating Income amounts to 82.6m USD.

What is NuVasive Inc's Operating Income growth rate?
Operating Income CAGR 10Y
13%

Over the last year, the Operating Income growth was 45%. The average annual Operating Income growth rates for NuVasive Inc have been 13% over the past three years , -6% over the past five years , and 13% over the past ten years .

Back to Top